MRS2-1 Antibody

What are the known structural characteristics of human MRS2?

Human MRS2 forms symmetrical pentamers with consistent conformational features across different conditions. Cryo-electron microscopy (cryo-EM) reconstructions have revealed special structural features, notably a Cl⁻-bound R-ring composed of five Arg332 residues . This structural arrangement is critical for understanding the mechanism of magnesium permeation. Molecular dynamics simulations suggest that the R-ring functions as a charge repulsion barrier, while Cl⁻ may serve as a "ferry" to jointly gate Mg²⁺ permeation . The protein is anchored to the inner mitochondrial membrane, and mitochondrial membrane potential likely serves as the driving force for Mg²⁺ permeation .

What experimental models are available for studying MRS2 function?

Several experimental models have been developed for studying MRS2 function:

• Cell culture models: HEK293 cells with stable expression of MRS2-Flag or Mrs2 knockdown (Mrs2KD)

• Liver-specific knockout mice: Mrs2ᶠˡ/ᶠˡ mice crossed with Albumin-Cre to generate liver-specific deletion (Mrs2ᐩʰᵉᵖ)

• Permeabilized cell systems: For simultaneous measurement of mitochondrial Mg²⁺ uptake and membrane potential

• Mitoplast patch-clamp recordings: To directly measure Mrs2 currents and MCU activity

These models allow researchers to investigate the consequences of MRS2 deletion or modification on mitochondrial magnesium homeostasis, calcium handling, and cellular metabolism.

What are the optimal methods for detecting MRS2 expression in tissue samples?

For detecting MRS2 expression in tissue samples, researchers should consider a multi-approach strategy:

Western Blotting:

• Use affinity-purified antibodies at concentrations of 0.04-0.4 μg/mL

• Target specific epitopes like amino acids 211-223 for reliable detection

• Include appropriate controls (e.g., MRS2 knockout tissues) to validate specificity

Immunohistochemistry:

• Recommended dilutions range from 1:200 to 1:500

• Use paraffin-embedded tissues for optimal results

• Apply antigen retrieval methods to enhance signal detection

Subcellular Fractionation:

• Perform mitochondrial isolation followed by proteinase K digestion to confirm mitochondrial localization

• Prepare mitoplasts to verify matrix-facing orientation of C-terminal domains

Validation of antibody specificity is crucial, as demonstrated in studies using liver-specific MRS2 knockout models where loss of MRS2 was confirmed by both qPCR and Western blot analysis .

How can researchers accurately measure mitochondrial Mg²⁺ uptake in experimental models?

Accurate measurement of mitochondrial Mg²⁺ uptake requires sophisticated techniques:

• Permeabilized Cell System with Ratiometric Dyes:

  • Use digitonin (40 μg/ml) to selectively permeabilize the plasma membrane while keeping mitochondria intact

  • Load cells with Mag-Fura-2 tetra potassium salt (Kd = 1.98 mM)

  • Measure fluorescence at 340/380 nm excitation using a multi-wavelength spectrofluorometer

  • Calculate mitochondrial [Mg²⁺] using the formula: [Mg²⁺] = Kd × (R-Rmin)/(Rmax-R)

• Simultaneous Measurement of Membrane Potential:

  • Combine Mg²⁺ measurements with membrane potential indicators

  • This controls for potential confounding effects of membrane depolarization on ion flux

• Calibration and Validation:

  • Perform CCCP-induced mitochondrial depolarization to measure total matrix [Mg²⁺]

  • Compare results between wild-type and MRS2-deficient models to validate specificity

• Mitoplast Patch-Clamp Recordings:

  • Directly measure Mrs2 currents in isolated mitoplasts

  • Use specific inhibitors (e.g., hexamine cobalt(III)chloride) to confirm current identity

  • Include controls with ruthenium red (Ru360) to differentiate from MCU currents

What controls should be included when studying MRS2 knockout models?

When studying MRS2 knockout models, several critical controls should be included:

These controls help ensure that observed phenotypes are specifically attributable to MRS2 deficiency rather than secondary effects or compensatory mechanisms.

How does matrix Mg²⁺ concentration influence mitochondrial Ca²⁺ uptake through MCU?

Research has revealed a complex relationship between mitochondrial magnesium and calcium handling:

• Inverse Relationship: Loss of MRS2 and subsequent decrease in matrix [Mg²⁺] leads to increased MCU activity and enhanced mitochondrial Ca²⁺ uptake .

• Mechanistic Basis:

  • Mg²⁺ does not directly bind to MCU complex components (MCU, MICU1, MCUR1, EMRE)

  • Rather, Mg²⁺ acts as a regulatory ion that affects MCU channel properties

  • Previous research showed Mg²⁺ binding to the MRAP region destabilizes and shifts MCU self-association equilibrium to monomer form

• Low [iCa²⁺] Regime Activation:

  • MRS2 deficiency activates MCU even in low cytosolic calcium conditions

  • This occurs despite stable MCU/MICU1 interaction

  • The phenotype can be rescued by expression of MCU ΔDIME mutant, confirming it is MCU-channel mediated

• Experimental Validation:

  • Permeabilized MRS2-deficient cells show increased Ca²⁺ clearance from bath

  • Mitoplast patch-clamp recordings confirm increased MCU currents (IMCU) in MRS2 knockout models

  • Matrix [Ca²⁺] measurements reveal higher accumulation when MCU inhibition is removed

These findings establish matrix [Mg²⁺] as a critical regulator of MCU activity, functioning as a "cationic rheostat" for calcium uptake.

What are the challenges in differentiating MRS2-mediated effects from other mitochondrial channels?

Differentiating MRS2-mediated effects from other mitochondrial channels presents several methodological challenges:

• Electrophysiological Discrimination:

  • MRS2 currents must be distinguished from other ion currents, particularly MCU

  • Solution: Use specific inhibitors like hexamine cobalt(III)chloride (blocks MRS2) and ruthenium red/Ru360 (blocks MCU)

  • Validate current identity through mitoplast patch-clamp recordings with these inhibitors

• Functional Overlap:

  • Both MRS2 and MCU affect mitochondrial cation homeostasis

  • MRS2 deficiency alters MCU activity, creating complex phenotypes

  • Solution: Design experiments with sequential inhibition of different channels and measure outcomes

• Protein-Protein Interactions:

  • Determine if observed effects are due to direct or indirect interactions

  • Immunoprecipitation studies can reveal physical associations between channel components

  • Research shows MRS2 does not directly interact with MCU complex components

• Genetic Approaches:

  • Generate double knockout models (e.g., MRS2/MCU) to dissect individual contributions

  • Use domain-specific mutations to identify functional regions without complete protein loss

• Temporal Resolution:

  • Acute vs. chronic effects of MRS2 deficiency may differ due to compensatory mechanisms

  • Solution: Use inducible knockout systems or acute inhibition approaches

How can researchers interpret contradictory data regarding MRS2 function in different tissues?

When facing contradictory data about MRS2 function across different tissues, researchers should consider:

• Tissue-Specific Expression Patterns:

  • MRS2 may have varying expression levels in different tissues

  • Confirm expression levels with quantitative methods (qPCR, Western blot) in each tissue studied

• Metabolic Context Differences:

  • Tissues have different metabolic demands and magnesium requirements

  • For example, MRS2 deficiency in liver (Mrs2ᐩʰᵉᵖ) prevents hepatic steatosis during prolonged Western diet

  • While in adipose tissue, MRS2 deficiency induces browning of white adipose tissue

• Compensatory Mechanisms:

  • Alternative magnesium transport systems may be upregulated in specific tissues

  • Analyze expression of other magnesium transporters in MRS2-deficient tissues

  • Compare acute vs. chronic knockout effects to identify compensatory adaptations

• Experimental Design Variations:

  • Different methodologies may contribute to apparently contradictory results

  • Standardize experimental conditions across tissue studies

  • Perform parallel experiments in different tissues simultaneously

• Integration of Multi-Omics Data:

  • RNA-seq analyses reveal tissue-specific transcriptional responses to MRS2 deficiency

  • In adipose tissue, MRS2 knockout upregulates beige markers and fatty acid catabolism genes

  • Integrate transcriptomic, proteomic, and metabolomic data to understand tissue-specific responses

What is the current understanding of the molecular mechanism of Mg²⁺ permeation through MRS2?

Recent cryo-electron microscopy studies have significantly advanced our understanding of Mg²⁺ permeation through human MRS2:

• Structural Foundation:

  • Human MRS2 forms symmetrical pentamers with consistent conformations across various conditions

  • A special structural feature called the "R-ring" consists of five Arg332 residues

  • The R-ring can bind chloride ions (Cl⁻), which appears crucial for function

• Permeation Mechanism:

  • Molecular dynamics simulations suggest the R-ring functions as a charge repulsion barrier

  • Cl⁻ may function as a "ferry" to jointly gate Mg²⁺ permeation through the channel

  • The membrane potential likely serves as the driving force for Mg²⁺ permeation

• Ion Selectivity:

  • The channel demonstrates selectivity for Mg²⁺ over other cations

  • The structural basis for this selectivity involves specific coordination sites within the pore

  • Charge distribution and pore dimensions contribute to selective Mg²⁺ permeation

• Gating Regulation:

  • Unlike bacterial CorA, human MRS2 appears to maintain similar conformations in different conditions

  • Regulatory mechanisms may involve interactions with other mitochondrial proteins or metabolites

  • Membrane potential fluctuations likely influence channel gating behavior

This molecular understanding provides a framework for investigating how MRS2 dysfunction contributes to various pathological conditions and potential therapeutic approaches.

What role does MRS2 play in metabolic diseases and how can it be therapeutically targeted?

Research has uncovered important connections between MRS2 function and metabolic diseases:

How does MRS2 interact with the mitochondrial calcium uniporter complex to regulate cellular metabolism?

The interaction between MRS2 and the mitochondrial calcium uniporter (MCU) complex represents a sophisticated regulatory mechanism:

• Indirect Regulatory Relationship:

  • MRS2 does not physically interact with MCU complex components (MCU, MICU1, MCUR1, EMRE)

  • Instead, MRS2-mediated control of matrix [Mg²⁺] indirectly regulates MCU activity

  • Matrix [Mg²⁺] functions as a "cationic rheostat" for MCU-mediated calcium uptake

• Mechanism of MCU Regulation:

  • Mg²⁺ binding to the MRAP region destabilizes MCU oligomers

  • MRS2 deficiency and reduced matrix [Mg²⁺] activate MCU even in low cytosolic calcium conditions

  • This changes the threshold for MCU activation and affects calcium signaling dynamics

• Metabolic Consequences:

  • Altered calcium handling affects mitochondrial metabolism in multiple ways:

    • Calcium activates TCA cycle enzymes

    • Influences mitochondrial fission/fusion dynamics

    • Affects respiratory chain activity

  • These changes collectively impact cellular energy production and substrate utilization

• Experimental Evidence:

  • MRS2-deficient models show increased MCU currents in mitoplast patch-clamp recordings

  • Expression of MCU ΔDIME mutant reverses the increased calcium uptake phenotype

  • The MCU/MICU1 complex remains intact in MRS2-deficient cells, confirming indirect regulation

• Physiological Implications:

  • The MRS2-MCU regulatory axis may help coordinate magnesium and calcium homeostasis

  • This coordination is crucial for maintaining proper mitochondrial function under varying energetic demands

  • Disruption of this regulation could contribute to pathological conditions involving mitochondrial dysfunction

What are common pitfalls when using MRS2 antibodies in experimental procedures?

Researchers should be aware of several potential pitfalls when using MRS2 antibodies:

• Antibody Specificity Issues:

  • MRS2 antibodies may cross-react with related proteins

  • Always include negative controls (e.g., MRS2 knockout samples) to confirm specificity

  • Choose antibodies that target unique epitopes of MRS2, such as AA 211-223

• Subcellular Localization Challenges:

  • MRS2's mitochondrial localization requires proper sample preparation

  • Standard cell lysis methods may not adequately preserve mitochondrial proteins

  • Use mitochondrial isolation followed by proteinase K protection assays to confirm localization

• Signal Interpretation:

  • MRS2 is an integral membrane protein, requiring appropriate extraction methods

  • Use detergents suitable for membrane protein extraction (e.g., digitonin 40 μg/ml)

  • Be aware that standard immunoprecipitation protocols may need optimization for membrane proteins

• Quantification Accuracy:

  • Standardize loading controls specifically for mitochondrial proteins (e.g., VDAC, Complex IV)

  • Normalize MRS2 expression to mitochondrial content rather than total cellular protein

  • Consider using ratiometric approaches with multiple antibodies targeting different MRS2 epitopes

• Fixation and Processing Effects:

  • For immunohistochemistry, fixation methods can affect antibody accessibility to MRS2

  • Optimize antigen retrieval methods for mitochondrial membrane proteins

  • Compare results across multiple fixation protocols

How can researchers accurately quantify the effects of MRS2 manipulation on mitochondrial function?

Accurate quantification of MRS2 manipulation effects requires multi-parameter assessment:

• Integrated Measurement Approaches:

  • Combine magnesium flux measurements with membrane potential monitoring

  • Use ratiometric dyes like Mag-Fura-2 (Kd = 1.98 mM) for accurate Mg²⁺ quantification

  • Simultaneously measure additional parameters like respiration or ATP production

• Comprehensive Mitochondrial Assessment:

  • Oxygen consumption rate (OCR) measurements using respirometry

  • Membrane potential assessment with potentiometric dyes

  • ATP production capacity through luciferase-based assays

  • ROS production using specific fluorescent probes

• Morphological Analysis:

  • Evaluate mitochondrial network structure using confocal microscopy

  • Assess interactions between mitochondria and other organelles (e.g., lipid droplets)

  • Quantify mitochondrial size, number, and distribution

• Molecular Composition Analysis:

  • Monitor expression of respiratory chain complexes

  • Assess assembly and activity of complex I, which is particularly dependent on MRS2

  • Measure mitochondrial DNA copy number and transcription

• Dynamic Functional Testing:

  • Challenge mitochondria with substrates, uncouplers, or inhibitors

  • Assess capacity to respond to increased energy demands

  • Compare acute vs. chronic effects of MRS2 manipulation

What strategies can be employed to distinguish direct MRS2 effects from secondary adaptations in knockout models?

Distinguishing direct MRS2 effects from secondary adaptations requires sophisticated experimental design:

• Temporal Manipulation Strategies:

  • Use inducible knockout systems to control the timing of MRS2 deletion

  • Compare acute (hours/days) vs. chronic (weeks/months) effects

  • Track changes over time to identify primary vs. secondary responses

• Graded Expression Approaches:

  • Employ RNA interference with varying knockdown efficiency

  • Create hypomorphic alleles with partial function

  • Titrate expression levels using controlled promoter systems

• Rescue Experiments:

  • Re-express wild-type MRS2 in knockout backgrounds

  • Introduce structure-function mutants that separate different MRS2 activities

  • Use tissue-specific rescue to identify cell-autonomous effects

• Pharmacological Validation:

  • Use acute chemical inhibition to complement genetic approaches

  • Compare pharmacological inhibition with genetic deletion phenotypes

  • Apply inhibitors at different timepoints in knockout models

• Multi-Omics Integration:

  • Track transcriptional, proteomic, and metabolomic changes after MRS2 manipulation

  • Identify early response genes versus late adaptation signatures

  • Use pathway analysis to distinguish primary effects from compensatory responses

• In vivo vs. Ex vivo Comparison:

  • Analyze freshly isolated tissues from knockout models

  • Compare with cultured cells derived from the same models

  • Identify context-dependent adaptations that occur in the intact organism